EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy

Peter A Maple iD, Radu Tanasescu iD, Cris S Constantinescu iD, Paola Valentino iD, Marco Capobianco, Silvia D'Orso, Giovanna Borsellino iD, Luca Battistini iD, Giovanni Ristori, Rosella Mechelli iD, Marco Salvetti iD, Bruno Gran iD

Pathogens · 2024

DOI: 10.3390/pathogens13060499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Peter A Maple und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health and Clinical Neuroscience Academic Unit, University of Nottingham School of Medicine, Nottingham NG7 2UH, UK. Hauptthemen laut MEDLINE: Antibodies, Viral, Multiple Sclerosis, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Italian Multiple SclerosisFoundation, Italian Multiple Sclerosis Foundation (FISM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous exposure to Epstein–Barr virus (EBV) is strongly associated with the development of multiple sclerosis (MS). By contrast, past cytomegalovirus (CMV) infection may have no association, or be negatively associated with MS. This study aimed to investigate the associations of herpesvirus infections with MS in an Italian population. Serum samples (n = 200) from Italian people with multiple sclerosis (PwMS) classified as the relapsing-and-remitting clinical phenotype and (n = 137) healthy controls (HCs) were obtained from the CRESM Biobank, Orbassano, Italy. Both PwMS and HCs samples were selected according to age group (20–39 years, and 40 or more years) and sex. EBV virus capsid antigen (VCA) IgG, EBV nucleic acid-1 antigen (EBNA-1) IgG, CMV IgG, herpes simplex virus (HSV) IgG, and varicella zoster virus (VZV) IgG testing was undertaken using commercial ELISAs. EBV VCA IgG and EBNA-1 IgG seroprevalences were 100% in PwMS and 93.4% and 92.4%, respectively, in HCs. EBV VCA IgG and EBNA-1 IgG levels were higher (p < 0.001) in PwMS compared with HCs. For PwMS, the EBNA-1 IgG levels decreased with age, particularly in females. The CMV IgG seroprevalence was 58.7% in PwMS and 62.9% in HCs. CMV IgG seroprevalence increased with age. The HSV IgG seroprevalence was 71.2% in PwMS and 70.8% in HCs. HSV IgG levels were lower (p = 0.0005) in PwMS compared with HCs. VZV IgG seroprevalence was 97.5% in PwMS and 98.5% in HCs. In the population studied, several herpesvirus infections markers may have been influenced by the age and sex of the groups studied. The lack of a negative association of MS with CMV infection, and the observation of lower levels of HSV IgG in PwMS compared with HCs are findings worthy of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralMultiple SclerosisHerpesvirus 4, HumanEpstein-Barr Virus InfectionsImmunoglobulin GCytomegalovirusHerpesvirus 3, HumanHumansItalyFemaleMaleAdultSeroepidemiologic StudiesYoung AdultMiddle AgedSimplexvirusHerpes SimplexCytomegalovirus InfectionsVaricella Zoster Virus Infection

Stichwörter der Autor:innen

Epstein–Barr virusItalyantibody levelscytomegalovirusherpes simplex virushuman herpesvirusesmultiple sclerosisseroprevalencevaricella zoster virus

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Mental Health and Clinical Neuroscience Academic Unit, University of Nottingham School of Medicine, Nottingham NG7 2UH, UK.
  • Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.
  • Cooper Neurological Institute, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
  • Neuroscience Institute, Cavalieri Ottolenghi, 10043 Orbassano, Italy.
  • Department of Experimental Neuroscience, IRCSS Foundation Santa Lucia, 00179 Rome, Italy.
  • Department of Neurosciences, Mental Health and Sensory Organs, Centre for Experimental Neurological Therapies (CENTERS), Sapienza University of Rome, 00185 Rome, Italy.

ORCID-Profile: Peter A Maple, Radu Tanasescu, Cris S Constantinescu, Paola Valentino, Giovanna Borsellino, Luca Battistini, Rosella Mechelli, Marco Salvetti, Bruno Gran

Förderung

  • Medical Research Council
  • Italian Multiple SclerosisFoundation
  • Italian Multiple Sclerosis Foundation (FISM)

Zitieren

APA

Maple, P. A., Tanasescu, R., Constantinescu, C. S., Valentino, P., Capobianco, M., D'Orso, S., Borsellino, G., Battistini, L., Ristori, G., Mechelli, R., Salvetti, M., & Gran, B. (2024). Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. Pathogens. https://doi.org/10.3390/pathogens13060499

Vancouver

Maple PA, Tanasescu R, Constantinescu CS, Valentino P, Capobianco M, D'Orso S, et al. Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. Pathogens. 2024. doi:10.3390/pathogens13060499

BibTeX
@article{Maple2024,
  author = {Maple, Peter A and Tanasescu, Radu and Constantinescu, Cris S and Valentino, Paola and Capobianco, Marco and D'Orso, Silvia and Borsellino, Giovanna and Battistini, Luca and Ristori, Giovanni and Mechelli, Rosella and Salvetti, Marco and Gran, Bruno},
  title = {Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13060499}
}
Kostenlos starten →